Compositions for activating pyruvate kinase
Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD).
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
17.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD). |
---|---|
Bibliography: | Application Number: US201916593523 |